Materials Planning, Classification and Standardization

Introduction

Materials management in health care is concerned with ensuring that the right item is available, in the right quantity and quality, at the right place and time, at an acceptable total cost. In a hospital, materials include medicines, surgical supplies, laboratory reagents, implants, linen, food, engineering spares, information-technology equipment and general consumables. Although these items differ greatly in clinical purpose and technical characteristics, they share a common managerial requirement: decisions must be based on reliable information about need, specification, quantity, cost, risk and use.

Materials planning therefore extends beyond purchasing. It links clinical demand, inventory policy, budgets, supplier markets, storage capacity, patient safety and organizational strategy. Poor planning may cause stock-outs, cancelled procedures, expiry, emergency purchases, excessive working capital and unsafe substitutions. Effective planning reduces unwarranted variation while preserving clinically justified choice.

This chapter examines classification, codification, cataloguing, specification writing, standardization, simplification, value analysis and utilization review. It also explains how to develop a material master and how managers can collaborate with clinicians without allowing either procurement convenience or professional preference to dominate patient-care decisions.

Learning Objectives

By the end of this chapter, the learner should be able to:

1. Explain the role of materials planning in health-care operations.
2. Classify materials using value, criticality, demand and risk dimensions.
3. Design a practical coding and cataloguing structure.
4. Write clear, functional and non-discriminatory specifications.
5. Distinguish standardization, simplification, substitution and rationalization.
6. Apply value analysis and utilization review to reduce avoidable variation.
7. Develop governance requirements for a reliable material master.
8. Evaluate ethical, regulatory and implementation issues in materials decisions.

1. Materials Planning as a Clinical and Managerial Process

Materials planning converts expected service requirements into decisions about what should be available, when, in what quantity and under what controls. It begins with a demand signal, such as an operating-room schedule, outpatient attendance forecast, formulary decision, laboratory test volume or maintenance plan. The signal is translated into a bill of materials, consumption estimate or service-level requirement. Procurement and inventory policies then determine replenishment, inspection, storage and issue.

A useful planning logic is:

Clinical/service demand → requirements definition → classification → specification → sourcing → receipt and storage → issue and utilization review → feedback.

The process is cyclical. Actual consumption, wastage, substitutions, adverse events and clinician feedback should revise future plans. A purely historical approach can reproduce waste; a purely forecast-based approach can ignore real operational behavior.

Demand characteristics

Demand may be:

• Independent: demand is determined by patients, clinicians or external conditions, such as gloves or emergency medicines.
• Dependent: demand is derived from a planned service or procedure, such as sutures required for a scheduled operation.
• Stable: relatively predictable over time.
• Intermittent: occurs irregularly, as with rare implants or emergency antidotes.
• Seasonal: varies with predictable periods, such as influenza-related supplies.
• Perishable or time-sensitive: value declines through expiry, degradation or obsolescence.

Planning should also consider lead time, supplier reliability, minimum order quantities, storage conditions, shelf life, substitutes, regulatory status and the consequences of non-availability. A low-cost item may deserve stringent control if its absence can stop a critical service.

Basic inventory relationships

For a review period, the inventory position can be expressed as:

All terms must refer to the same item, unit of measure and time point. On-hand stock should exclude quarantined, expired or unusable units. Allocated stock is reserved for an identified requirement and should not be treated as freely available.

A simple reorder point under relatively stable demand is:

The model assumes that demand and lead time are measured consistently and that replenishment arrives before usable stock is exhausted. Safety stock should reflect demand variability, lead-time uncertainty and the required service level; it should not be used as an unexplained buffer for poor planning.

2. Classification: Creating Meaningful Management Categories

Classification groups materials according to characteristics that influence decisions. No single classification is sufficient for a hospital. A robust system uses several complementary dimensions.

2.1 Classification by nature and use

Common functional groups include:

2.2 ABC analysis: annual usage value

ABC analysis ranks items by annual consumption value. For item i:

The result is sorted from highest to lowest and cumulative percentages are calculated. An organization may designate A items as the small proportion of items accounting for the largest share of value, B items as intermediate, and C items as the large proportion accounting for the smallest share. The exact cut-offs are policy choices, not universal laws.

ABC analysis supports differentiated control. A items may receive frequent review, accurate records, senior approval and close supplier monitoring. C items may use simpler replenishment methods. ABC does not measure clinical importance: a cheap emergency antidote may be a C item by value but highly critical.

2.3 VED analysis: criticality

VED classifies items as:

• Vital: non-availability may threaten life or cause serious service interruption.
• Essential: non-availability causes significant operational difficulty but alternatives may exist.
• Desirable: non-availability is inconvenient but unlikely to harm care or operations.

Criticality should be assessed by a multidisciplinary group and supported by contingency arrangements. It must not be inferred only from price.

2.4 FSN, HML and other dimensions

FSN classifies items as fast-moving, slow-moving or non-moving. It highlights dormant inventory, expiry risk and opportunities for redistribution. HML classifies items as high, medium or low unit cost. SDE identifies scarce, difficult-to-procure and easily available items. XYZ may classify items according to the predictability or value of stock held.

A hospital can combine dimensions in a matrix. For example, a high-value, vital, intermittent implant requires different governance from a low-value, fast-moving dressing. Multidimensional classification is more informative than a single ranking, but it requires clean data and clear ownership.

3. Codification, Cataloguing and the Material Master

Codification

Codification assigns a unique identifier to each approved material. A good code is unique, stable, non-semantic where possible and independent of supplier marketing language. A sequential identifier is often safer than a code that embeds price, department or specification, because those attributes may change.

A code should not be reused after deletion. Reuse creates dangerous ambiguity in historical transactions, contracts, recalls and clinical records. Units of measure must be explicit: “each,” “box of 100,” “millilitre” and “case” are not interchangeable.

Cataloguing

Cataloguing provides the structured description that allows users to identify and compare items. A catalogue record commonly contains:

• unique material code;
• standardized short and long descriptions;
• clinical or functional category;
• base unit and purchasing unit;
• manufacturer and catalogue reference, where relevant;
• generic technical attributes;
• storage and handling requirements;
• regulatory and safety information;
• approved suppliers and contract status;
• substitution and interchangeability rules;
• expiry, lot and serial-number requirements;
• status, owner, approval date and review date.

Descriptions should follow a consistent syntax, such as noun + modifying attributes + size/capacity + presentation. “Glove, examination, nitrile, medium, powder-free, box of 100” is more useful than “medical gloves.” Descriptions must not conceal clinically important attributes or imply approval of a particular brand when a functional description is intended.

Material master governance

The material master is a controlled organizational data asset. A governance model should define who may create, amend, approve, deactivate and audit records. Duplicate detection, mandatory fields, controlled vocabularies and periodic cleansing are essential. A change to a material may affect purchasing, stock valuation, clinical preference cards, electronic ordering, traceability and patient billing; therefore changes require impact assessment.

Technology can assist with duplicate detection and natural-language normalization, but automated creation should be subject to human review. AI may suggest that “5 ml syringe,” “syringe 5 mL” and “5-mL syringe” are probable duplicates, but it should not decide clinical interchangeability without authorized expert validation.

4. Specification Writing

A specification translates a service or clinical need into verifiable requirements. It should describe what the item must do, not merely what a favored supplier sells.

A strong specification contains:

1. Purpose: the intended use and operating context.
2. Performance requirements: measurable function, capacity, accuracy or durability.
3. Safety requirements: relevant infection-control, biocompatibility, electrical or occupational-safety criteria.
4. Compatibility: interfaces with equipment, software, connectors or procedures.
5. Environmental requirements: temperature, humidity, sterility and storage conditions.
6. Packaging and labelling: unit quantities, lot identification and expiry information.
7. Verification method: inspection, testing, certification or clinical evaluation.
8. Acceptance criteria: conditions for approval or rejection.

Specifications should use “shall” for mandatory requirements and measurable language wherever possible. Terms such as “high quality,” “premium” or “user-friendly” are inadequate unless operationally defined.

Brand names, patents and proprietary dimensions should be avoided unless genuine compatibility, regulatory or clinical reasons justify them. Where a brand reference is necessary, procurement documents should state “or equivalent,” together with objective equivalence criteria, subject to applicable law and patient-safety requirements.

Clinicians should define the functional and clinical need; procurement specialists should test market neutrality, competition and contractual feasibility; infection-prevention, biomedical engineering, pharmacy, finance and quality personnel should contribute when relevant. This division prevents both technically unsuitable purchasing and unjustified preference capture.

5. Standardization, Simplification and Rationalization

These concepts are related but distinct.

• Standardization establishes a common approved specification, product, process or practice where variation is unnecessary.
• Simplification reduces unnecessary variety, such as carrying fewer sizes or pack configurations while retaining required functionality.
• Substitution replaces one item with another that is demonstrated to be clinically and technically acceptable.
• Rationalization evaluates the entire range and removes, retains or redesigns items according to evidence, risk and value.

Standardization can improve purchasing leverage, staff familiarity, training, storage efficiency, stock visibility and emergency substitution. It can also create risks if a single standard fails, if innovation is blocked, or if a cheaper product increases adverse events or staff time. Therefore standardization should be based on total value rather than unit price.

A practical standardization process is:

1. Map current products, suppliers, prices, usage and outcomes.
2. Identify clinically meaningful differences.
3. Form a multidisciplinary evaluation team.
4. Define minimum functional and safety requirements.
5. Evaluate alternatives through evidence, trials and user feedback.
6. Assess total cost, supply resilience and implementation impact.
7. Approve a preferred range with justified exceptions.
8. Monitor outcomes, complaints, substitutions and adverse events.

Exceptions should be transparent rather than informal. A clinician may require a non-standard item for a rare patient condition, but the reason, authorization and review date should be recorded.

6. Value Analysis and Utilization Review

Value analysis

Value analysis is a systematic examination of the relationship between function, performance, risk and total cost. It asks whether a required function can be achieved more effectively, safely or economically—not simply whether the purchase price can be reduced.

Total cost may include acquisition, freight, inspection, storage, preparation, training, maintenance, consumables, downtime, waste, disposal and consequences of failure. A low-price device may be poor value if it has a short life, requires proprietary accessories or increases procedure time.

The functional question is central: “What function must be delivered, and what evidence demonstrates acceptable performance?” This approach helps prevent specifications from becoming historical descriptions of familiar products.

Utilization review

Utilization review examines whether materials are used appropriately, consistently and in accordance with policy, evidence and patient need. It may assess:

• quantity used per procedure;
• rate of opened-but-unused items;
• variation among clinicians or units;
• use of non-preferred products;
• expiry and wastage;
• complication or return rates;
• adherence to formulary or procedure standards.

Variation is not automatically waste. Legitimate variation may reflect patient acuity, comorbidity, clinician judgment or service complexity. Review should therefore adjust for case mix where possible and avoid punitive comparisons based on crude averages.

Useful measures include stock-out frequency, inventory accuracy, expiry loss, emergency-order frequency, catalogue duplication, percentage of purchases through contract and cost per standardized procedure. Each metric needs a defined numerator, denominator, data source and review period.

7. Applied Case: Standardizing Surgical Skin-Closure Materials

The following is an illustrative case, not a report of a specific hospital.

Background

A 450-bed hospital stocked 18 brands and 11 configurations of skin-closure strips and adhesive products. Annual expenditure was moderate, but operating rooms reported frequent substitutions and nurses spent considerable time locating suitable items.

Problem

The procurement department proposed selecting the cheapest product. Surgeons resisted, arguing that different procedures and patient skin conditions required different performance characteristics. The hospital lacked reliable usage data because descriptions and units of measure differed across departments.

Analysis

A multidisciplinary team consolidated catalogue records and found that six descriptions represented duplicate or near-duplicate products. It separated products by required function: routine closure, high-tension closure and use on sensitive skin. The team reviewed opening waste, skin reactions, closure failures, procedure delays and unit prices. It also confirmed that some apparent price differences resulted from different pack sizes.

Approach and solution

The team wrote functional specifications covering adhesive performance, skin compatibility, package integrity, lot traceability and pack presentation. Two products were selected as preferred options for routine use, while a specialized option remained available under a documented exception pathway. Preference cards were updated, staff were trained and stock locations were labelled. A contingency supplier was qualified for the routine product.

Outcome

After six months, catalogue duplication had decreased, stock visibility improved and emergency substitutions fell. The hospital did not eliminate all variation; it retained a clinically justified specialized option. The evaluation also showed that the cheapest unit-price product generated more opened-but-unused waste, so the preferred decision was based on total value rather than purchase price.

Learning points

The case demonstrates that standardization is not synonymous with imposing one product. It requires reliable master data, functional specifications, clinician participation, objective evaluation, documented exceptions and post-implementation measurement.

8. Governance, Ethics and Regulation

Materials decisions can affect patient safety, professional autonomy, competition, public expenditure and equity. Governance should address conflicts of interest, gifts and sponsorship, transparent evaluation criteria, segregation of duties and auditability. Committee members should declare relationships with suppliers and recuse themselves where appropriate.

Regulatory requirements may include medical-device authorization, pharmaceutical controls, sterilization standards, electrical safety, cold-chain management, controlled-substance security, occupational safety and product recall procedures. Requirements vary by jurisdiction; managers must consult current national and institutional rules rather than rely on generic guidance.

Equity also matters. A decision that lowers cost but restricts access for patients with disabilities, unusual anatomy or special cultural needs may be unacceptable. Standardization must include an exception mechanism that is clinically responsive and administratively fair.

9. Challenges and Limitations

Common implementation barriers include incomplete consumption data, inconsistent units, duplicate records, clinician distrust, supplier influence, fragmented budgets and weak ownership of the catalogue. Classification thresholds may become arbitrary if they are copied from another organization without local analysis. ABC analysis can overemphasize expensive items, while VED judgments can become subjective. Utilization comparisons can be misleading when case mix and outcomes are ignored.

Change management is therefore essential. Leaders should explain the purpose, involve users early, pilot changes, publish decision criteria, provide feedback and monitor unintended effects. Standardization should be revisited as technology, evidence, prices and clinical practice evolve.

Best-Practice Framework

An effective materials-planning program should:

• maintain one governed material master;
• use multiple classification dimensions;
• distinguish functional need from brand preference;
• align specifications with measurable acceptance criteria;
• use total-cost and risk analysis;
• involve clinicians and technical experts;
• document justified exceptions;
• monitor utilization, outcomes and supply resilience;
• protect data quality and traceability;
• review standards periodically.

Chapter Summary

Materials planning is an integrated clinical, operational and financial activity. Classification provides differentiated control: ABC addresses annual usage value, VED addresses criticality, and FSN, HML and related systems address movement, unit cost and supply difficulty. Codification creates stable identifiers, while cataloguing and the material master provide structured, governed information.

Effective specifications describe function, performance, safety, compatibility and verification requirements without unnecessarily restricting competition. Standardization and simplification can reduce variation, waste and training burden, but they must preserve clinically necessary choice. Value analysis evaluates function and total cost, whereas utilization review examines actual use, variation and outcomes. Successful implementation depends on multidisciplinary governance, reliable data, transparent exceptions, regulatory compliance and continuous review.

Key Terms

Materials planning: Converting service requirements into decisions about item availability, quantity, timing and control.

Independent demand: Demand determined directly by patients, clinicians or external conditions.

Dependent demand: Demand derived from a planned service, procedure or production requirement.

ABC analysis: Classification by annual consumption value.

VED analysis: Classification by vital, essential and desirable criticality.

FSN analysis: Classification by fast-moving, slow-moving and non-moving behavior.

Codification: Assignment of a unique identifier to a material.

Cataloguing: Structured description and organization of material records.

Material master: Governed repository of approved material data.

Specification: Written statement of required function, performance and acceptance criteria.

Standardization: Establishing a common approved specification or product where appropriate.

Simplification: Reduction of unnecessary variety.

Substitution: Replacement by an item demonstrated to be acceptable.

Rationalization: Systematic review of the range of materials for retention, removal or redesign.

Value analysis: Evaluation of function, performance, risk and total cost.

Utilization review: Examination of whether materials are used appropriately and consistently.

Safety stock: Additional stock held to protect against uncertainty.

Interchangeability: The extent to which one item can replace another without unacceptable effect.

Exception pathway: A controlled process for authorizing justified non-standard use.

Review Questions

Short Answer Questions

1. Why is materials planning considered a clinical as well as a procurement activity?
2. Distinguish ABC analysis from VED analysis.
3. What information should a material master contain?
4. Why should a specification focus on function rather than brand name?
5. Define utilization review and state one measure it may examine.

Long Answer Questions

1. Explain how a hospital can use multidimensional classification to design differentiated inventory controls.
2. Discuss the principles of effective codification, cataloguing and material-master governance.
3. Compare standardization, simplification, substitution and rationalization, using health-care examples.
4. Explain how value analysis differs from unit-price comparison and why total cost matters.
5. Describe a multidisciplinary process for introducing a standardized clinical consumable.

Analytical / Application Questions

1. A hospital identifies a low-cost antidote that is rarely used but essential during a specific emergency. How should ABC and VED classifications guide its inventory policy?
2. Two departments use apparently different descriptions for the same syringe, but their pack sizes and units of measure differ. Design a data-cleansing and coding approach that avoids duplicate records and quantity errors.
3. Clinicians report that a proposed standardized device causes more procedure delays, although its purchase price is lower. Develop an evaluation framework that incorporates clinical outcomes, staff time, supply resilience and total cost.

Multiple Choice Questions with Answers

Question 1

Which classification primarily measures annual consumption value?

A. VED

B. ABC

C. FSN

D. SDE

Correct Answer: B. ABC

Question 2

What is the main purpose of a unique material code?

A. To identify the preferred supplier permanently

B. To encode the current purchase price

C. To distinguish one material record unambiguously

D. To replace the technical specification

Correct Answer: C. To distinguish one material record unambiguously

Question 3

Which statement best describes VED analysis?

A. It classifies items by movement rate

B. It classifies items by unit cost

C. It classifies items by supplier lead time

D. It classifies items by criticality

Correct Answer: D. It classifies items by criticality

Question 4

A sound specification should primarily describe:

A. The preferred salesperson’s product

B. The required function and verifiable performance

C. The historical purchase description

D. The cheapest available brand

Correct Answer: B. The required function and verifiable performance

Question 5

Which item is most likely to require high control despite low annual expenditure?

A. A vital emergency antidote

B. Routine office paper

C. A common cleaning cloth

D. A disposable visitor badge

Correct Answer: A. A vital emergency antidote

Question 6

In the inventory-position equation, allocated stock is:

A. Stock already reserved for an identified requirement

B. Expired stock awaiting disposal

C. Stock ordered but not yet delivered

D. Stock held by a supplier on consignment

Correct Answer: A. Stock already reserved for an identified requirement

Question 7

What is the principal risk of reusing a deleted material code?

A. Higher warehouse temperature

B. Ambiguity in historical and current transactions

C. Automatic reduction in supplier competition

D. Improved stock rotation

Correct Answer: B. Ambiguity in historical and current transactions

Question 8

Value analysis differs from simple price comparison because it considers:

A. Only the supplier’s location

B. Only the invoice amount

C. Function, risk, performance and total cost

D. Only the number of catalogue records

Correct Answer: C. Function, risk, performance and total cost

Question 9

Which is an example of simplification?

A. Adding five new brands to every ward

B. Reducing unnecessary pack and size variation

C. Changing an item code every month

D. Removing all clinical exceptions

Correct Answer: B. Reducing unnecessary pack and size variation

Question 10

Why must utilization comparisons consider case mix where possible?

A. To make all clinicians use identical quantities

B. Because crude differences may reflect legitimate patient complexity

C. To eliminate the need for clinical review

D. Because unit price is always irrelevant

Correct Answer: B. Because crude differences may reflect legitimate patient complexity